EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

An Anisotropic Gold‐Palladium Heterostructured Nanosystem for Synergistically Overcoming Radioresistance and Enhancing Melanoma Radioimmunotherapy

Cheng Chen, Yuqi Huang, Wandong Wang, Minghao Chao, Weiguo Sun, Yinghui Kong, Guan Jiang, Yong Gao, Fenglei Gao iD

Advanced Science · 2025

DOI: 10.1002/advs.202500492 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Advanced Science, 2025. Verfasst von Cheng Chen und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Dermatology, The Affiliated Huaian No. 1 People's Hospital of Nanjing Medical University, Jiangsu, 223300, P. R. China. Hauptthemen laut MEDLINE: Gold, Melanoma, Palladium, Radiation Tolerance. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 48 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Key Research and Development Program of China, National Natural Science Foundation of China, Jiangsu Provincial Outstanding Youth Fund.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Radiotherapy (RT) has recently reemerged as a promising approach for melanoma treatment because of its potential to trigger abscopal effects. However, the intrinsic radioresistance of melanoma significantly diminishes RT‐induced DNA damage and the subsequent release of immunostimulatory molecules, thereby impairing systemic antitumor immunity. To overcome these challenges, a multifunctional anisotropic Au‐Pd heterostructured nanosystem (APSMR) is developed that incorporates a plasmonically enhanced Au‐Pd core, with a shell composed of a biodegradable, Mn‐doped targeting peptide. The nanosystem integrates photothermal, radiotherapeutic, and immunomodulatory functions. Under 1064 nm laser irradiation, APSMR generates reactive oxygen species (ROS) via plasmon‐driven catalysis and Mn‐mediated Fenton‐like reactions. Concurrently, mild hyperthermia (HT) promotes oxygenation and disrupts DNA repair pathways, resulting in multi‐directional DNA damage and an increase in immunogenic cell death (ICD). Furthermore, the release of Mn 2 ⁺ ions activates the cGAS–STING pathway, which synergizes with ICD to promote systemic antitumor immunity. Notably, APSMR treatment also upregulates PD‐L1 expression, thereby sensitizing tumors to immune checkpoint blockade. Collectively, APSMR offers a potent and synergistic strategy to amplify RT‐driven tumor vaccination and improve therapeutic responses against metastatic melanoma.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

GoldMelanomaPalladiumRadiation ToleranceNanostructuresAnimalsMiceHumansCell Line, TumorReactive Oxygen Species

Stichwörter der Autor:innen

melanomamild hyperthermia therapynanovaccineradioimmunotherapy

Substanzen

GoldPalladiumReactive Oxygen Species

Autor:innen und Institutionen

  • Department of Dermatology, The Affiliated Huaian No. 1 People's Hospital of Nanjing Medical University, Jiangsu, 223300, P. R. China.
  • Department of Dermatology, The Affiliated Suzhou Hospital of Nanjing Medical University, Jiangsu, 215000, P. R. China.
  • Jiangsu Key Laboratory of New Drug Research and Clinical Pharmacy, Xuzhou Medical University, Jiangsu, 221004, P. R. China.
  • Department of Dermatology, University Medical Center Groningen, University of Groningen, Groningen, 9713 GZ, the Netherlands.
  • Department of Dermatology, Affiliated Hospital of Xuzhou Medical University, Xuzhou, Jiangsu, 221002, P. R. China.
  • Department of Oncology, The Affiliated Huaian No. 1 People's Hospital of Nanjing Medical University, Jiangsu, 223300, P. R. China.

ORCID-Profile: Fenglei Gao

Förderung

  • National Key Research and Development Program of China
  • National Natural Science Foundation of China
  • Jiangsu Provincial Outstanding Youth Fund
  • Key Project of the Jiangsu Provincial Health Commission
  • Jiangsu Provincial Natural Science Foundation Project
  • Key Cultivation Project of Natural Science Research from Northern Jiangsu Clinical Research Institute
  • High-Level Talent Research Start-up Fund of Huaian No. 1 People's Hospital of Nanjing Medical University
  • Project of Huaian Science and Technology Bureau (HAB2024003).

Zitieren

APA

Chen, C., Huang, Y., Wang, W., Chao, M., Sun, W., Kong, Y., Jiang, G., Gao, Y., & Gao, F. (2025). An Anisotropic Gold‐Palladium Heterostructured Nanosystem for Synergistically Overcoming Radioresistance and Enhancing Melanoma Radioimmunotherapy. Advanced Science. https://doi.org/10.1002/advs.202500492

Vancouver

Chen C, Huang Y, Wang W, Chao M, Sun W, Kong Y, et al. An Anisotropic Gold‐Palladium Heterostructured Nanosystem for Synergistically Overcoming Radioresistance and Enhancing Melanoma Radioimmunotherapy. Advanced Science. 2025. doi:10.1002/advs.202500492

BibTeX
@article{Chen2025,
  author = {Chen, Cheng and Huang, Yuqi and Wang, Wandong and Chao, Minghao and Sun, Weiguo and Kong, Yinghui and Jiang, Guan and Gao, Yong and Gao, Fenglei},
  title = {An Anisotropic Gold‐Palladium Heterostructured Nanosystem for Synergistically Overcoming Radioresistance and Enhancing Melanoma Radioimmunotherapy},
  journal = {Advanced Science},
  year = {2025},
  doi = {10.1002/advs.202500492}
}
Kostenlos starten →